TAOX
TAOX
TAO Synergies Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $203.37K ▲ | $2M ▼ | $-3.92M ▲ | -1.93K% ▲ | $-1.56 ▲ | $-1.8M ▲ |
| Q2-2025 | $3.96K ▲ | $3.04M ▲ | $-17.52M ▼ | -442.1K% ▼ | $-11.26 ▼ | $-2.34M ▼ |
| Q1-2025 | $0 | $1.07M ▼ | $385.17K ▲ | 0% | $0.12 ▲ | $-1.07M ▲ |
| Q4-2024 | $0 | $2.18M ▲ | $-5.55M ▲ | 0% | $-4.18 ▲ | $-2.18M ▼ |
| Q3-2024 | $0 | $1.36M | $-5.74M | 0% | $-4.58 | $-1.36M |
What's going well?
Revenue saw a huge jump this quarter, and net losses are much smaller than last quarter. Operating expenses are coming down, and the company has no debt burden.
What's concerning?
The business is still losing much more money than it brings in, and the large increase in share count hurts existing shareholders. High 'other' expenses and lack of cost discipline remain big red flags.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.45M ▼ | $18.36M ▼ | $1.69M ▼ | $16.67M ▼ |
| Q2-2025 | $14.37M ▼ | $19.79M ▲ | $1.83M ▼ | $17.96M ▲ |
| Q1-2025 | $14.83M ▼ | $15.33M ▼ | $8.88M ▼ | $6.45M ▼ |
| Q4-2024 | $17.66M ▼ | $17.73M ▼ | $10.96M ▲ | $6.78M ▼ |
| Q3-2024 | $22.07M | $22.83M | $9.71M | $13.12M |
What's financially strong about this company?
TAOX has no debt at all and a very high ratio of current assets to current liabilities, meaning it can easily pay its bills. The asset base is simple and tangible, with no risky goodwill or intangibles.
What are the financial risks or weaknesses?
Cash dropped dramatically this quarter, which could be a warning sign if it continues. Retained earnings are deeply negative, showing a history of losses, and book value is declining.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.92M ▲ | $-1.19M ▼ | $-13.07M ▼ | $1.34M ▼ | $-12.92M ▼ | $-1.19M ▼ |
| Q2-2025 | $-17.52M ▼ | $-749.07K ▲ | $-4.5M ▼ | $4.79M ▲ | $-463.55K ▲ | $-749.07K ▲ |
| Q1-2025 | $385.17K ▲ | $-2M ▼ | $0 | $-822.36K ▼ | $-2.82M ▼ | $-2M ▼ |
| Q4-2024 | $-19.99M ▼ | $-1.17M ▼ | $0 | $-801.69K ▲ | $-1.97M ▲ | $-1.17M ▼ |
| Q3-2024 | $8.7M | $-1.03M | $0 | $-4.32M | $-5.35M | $-1.03M |
What's strong about this company's cash flow?
Net loss improved significantly, dropping from -$17.5 million to -$3.9 million. Working capital changes provided a temporary cash boost.
What are the cash flow concerns?
Operating cash flow and free cash flow are both negative and worsening. Cash reserves are almost gone, and the company is highly dependent on raising more money to survive.
5-Year Trend Analysis
A comprehensive look at TAO Synergies Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a debt‑free balance sheet, historically strong short‑term liquidity, and a leaner cost base compared with prior years. Strategically, TAO Synergies holds a prominent position in a novel niche as an early, pure‑play public vehicle for Bittensor exposure, supported by meaningful TAO holdings and active staking. Its simple asset structure and focused thesis make the story easy to understand relative to more complex conglomerates.
Major risks are the absence of operating revenue, persistent and sometimes widening losses, and a steady erosion of cash and equity. The business is highly dependent on external capital and on the market value and viability of a single crypto ecosystem, exposing it to significant volatility and regulatory uncertainty. Reduced traditional R&D, while lowering costs, also limits diversification into other potential revenue streams, increasing dependence on the success of the decentralized AI strategy.
Looking ahead, TAO Synergies’ trajectory will largely mirror the fortunes of the Bittensor network and the TAO token, as well as management’s ability to control burn and raise capital when needed. If the ecosystem grows and staking economics remain attractive, the company could gradually transition from pure cash burn toward a more self‑sustaining model based on digital asset income. If adoption stalls or capital markets become less supportive, the combination of ongoing losses and a shrinking cash cushion would become more problematic. Overall, the outlook is opportunity‑rich but highly uncertain and tightly linked to external technological and market developments.
About TAO Synergies Inc.
https://www.synaptogen.comClinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $203.37K ▲ | $2M ▼ | $-3.92M ▲ | -1.93K% ▲ | $-1.56 ▲ | $-1.8M ▲ |
| Q2-2025 | $3.96K ▲ | $3.04M ▲ | $-17.52M ▼ | -442.1K% ▼ | $-11.26 ▼ | $-2.34M ▼ |
| Q1-2025 | $0 | $1.07M ▼ | $385.17K ▲ | 0% | $0.12 ▲ | $-1.07M ▲ |
| Q4-2024 | $0 | $2.18M ▲ | $-5.55M ▲ | 0% | $-4.18 ▲ | $-2.18M ▼ |
| Q3-2024 | $0 | $1.36M | $-5.74M | 0% | $-4.58 | $-1.36M |
What's going well?
Revenue saw a huge jump this quarter, and net losses are much smaller than last quarter. Operating expenses are coming down, and the company has no debt burden.
What's concerning?
The business is still losing much more money than it brings in, and the large increase in share count hurts existing shareholders. High 'other' expenses and lack of cost discipline remain big red flags.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.45M ▼ | $18.36M ▼ | $1.69M ▼ | $16.67M ▼ |
| Q2-2025 | $14.37M ▼ | $19.79M ▲ | $1.83M ▼ | $17.96M ▲ |
| Q1-2025 | $14.83M ▼ | $15.33M ▼ | $8.88M ▼ | $6.45M ▼ |
| Q4-2024 | $17.66M ▼ | $17.73M ▼ | $10.96M ▲ | $6.78M ▼ |
| Q3-2024 | $22.07M | $22.83M | $9.71M | $13.12M |
What's financially strong about this company?
TAOX has no debt at all and a very high ratio of current assets to current liabilities, meaning it can easily pay its bills. The asset base is simple and tangible, with no risky goodwill or intangibles.
What are the financial risks or weaknesses?
Cash dropped dramatically this quarter, which could be a warning sign if it continues. Retained earnings are deeply negative, showing a history of losses, and book value is declining.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.92M ▲ | $-1.19M ▼ | $-13.07M ▼ | $1.34M ▼ | $-12.92M ▼ | $-1.19M ▼ |
| Q2-2025 | $-17.52M ▼ | $-749.07K ▲ | $-4.5M ▼ | $4.79M ▲ | $-463.55K ▲ | $-749.07K ▲ |
| Q1-2025 | $385.17K ▲ | $-2M ▼ | $0 | $-822.36K ▼ | $-2.82M ▼ | $-2M ▼ |
| Q4-2024 | $-19.99M ▼ | $-1.17M ▼ | $0 | $-801.69K ▲ | $-1.97M ▲ | $-1.17M ▼ |
| Q3-2024 | $8.7M | $-1.03M | $0 | $-4.32M | $-5.35M | $-1.03M |
What's strong about this company's cash flow?
Net loss improved significantly, dropping from -$17.5 million to -$3.9 million. Working capital changes provided a temporary cash boost.
What are the cash flow concerns?
Operating cash flow and free cash flow are both negative and worsening. Cash reserves are almost gone, and the company is highly dependent on raising more money to survive.
5-Year Trend Analysis
A comprehensive look at TAO Synergies Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a debt‑free balance sheet, historically strong short‑term liquidity, and a leaner cost base compared with prior years. Strategically, TAO Synergies holds a prominent position in a novel niche as an early, pure‑play public vehicle for Bittensor exposure, supported by meaningful TAO holdings and active staking. Its simple asset structure and focused thesis make the story easy to understand relative to more complex conglomerates.
Major risks are the absence of operating revenue, persistent and sometimes widening losses, and a steady erosion of cash and equity. The business is highly dependent on external capital and on the market value and viability of a single crypto ecosystem, exposing it to significant volatility and regulatory uncertainty. Reduced traditional R&D, while lowering costs, also limits diversification into other potential revenue streams, increasing dependence on the success of the decentralized AI strategy.
Looking ahead, TAO Synergies’ trajectory will largely mirror the fortunes of the Bittensor network and the TAO token, as well as management’s ability to control burn and raise capital when needed. If the ecosystem grows and staking economics remain attractive, the company could gradually transition from pure cash burn toward a more self‑sustaining model based on digital asset income. If adoption stalls or capital markets become less supportive, the combination of ongoing losses and a shrinking cash cushion would become more problematic. Overall, the outlook is opportunity‑rich but highly uncertain and tightly linked to external technological and market developments.

CEO
Joshua N. Silverman
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 2 of 2
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
CITADEL ADVISORS LLC
Shares:141.72K
Value:$554.12K
QUADRATURE CAPITAL LTD
Shares:64.95K
Value:$253.97K
XTX TOPCO LTD
Shares:45.63K
Value:$178.41K
Summary
Showing Top 3 of 8

